Home / Products / Cancer (Tumor) Cell Lines / Ri-1
Ri-1
Datasheet Protocol

Ri-1

Cat. No. ARC0768
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Blood (peripheral blood)

Growth Properties:

Suspension

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

Ri-1 is a cancer cell line of diffuse large B cell lymphoma, isolated from in situ; peripheral blood.

Recommended Products

ILKAP Knockout Raji Polyclonal Cells ILKAP Knockout Raji Polyclonal Cells Cat. No. ARG23797 Braf Knockout RAW 264.7 Polyclonal Cells Braf Knockout RAW 264.7 Polyclonal Cells Cat. No. ARG23532 IL1R1 Knockout HAP1 Polyclonal Cells IL1R1 Knockout HAP1 Polyclonal Cells Cat. No. ARG35993 C2CD2 Knockout HGC-27 Polyclonal Cells C2CD2 Knockout HGC-27 Polyclonal Cells Cat. No. ARG41357 PDIK1L Knockout HCT116 Polyclonal Cells PDIK1L Knockout HCT116 Polyclonal Cells Cat. No. ARG6963 PBX3 Knockout MES-OV Polyclonal Cells PBX3 Knockout MES-OV Polyclonal Cells Cat. No. ARG6041
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Blood (peripheral blood)
Disease:
Diffuse large B cell lymphoma
Morphology:
Lymphoblast-like
Growth Mode:
Suspension
Age:
57 years
Sex of Donor:
Female
Derived From Site:
In situ; Peripheral blood
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

BUB1B Knockout HT29 Polyclonal Cells

BUB1B Knockout HT29 Polyclonal Cells

Cat. No. ARG23301
 BCL11B Knockout HEK293T Polyclonal Cells

BCL11B Knockout HEK293T Polyclonal Cells

Cat. No. ARG37839
 FAT1 Knockout 786-O Polyclonal Cells

FAT1 Knockout 786-O Polyclonal Cells

Cat. No. ARG5636
 GLCCI1 Knockout AGS Polyclonal Cells

GLCCI1 Knockout AGS Polyclonal Cells

Cat. No. ARG2967
 MAPK9 Knockout Raji Polyclonal Cells

MAPK9 Knockout Raji Polyclonal Cells

Cat. No. ARG2000
 Gstp3 Knockout Hepa 1-6 Cell Line

Gstp3 Knockout Hepa 1-6 Cell Line

Cat. No. ARG0368